Journal of Hazardous Materials Letters, published by ELSEVIER, is a premier open access journal that has rapidly gained prominence in the fields of Environmental Chemistry, Environmental Engineering, Health, Toxicology and Mutagenesis, Pollution, and Waste Management and Disposal since its inception in 2020. With an impressive categorization in the top quartile (Q1) across all its relevant disciplines in 2023, this journal ranks favorably within the Scopus database, positioning itself in the upper echelons of Environmental Science—ranked 23rd in Environmental Engineering and 19th in Health, Toxicology and Mutagenesis among its peers. It serves as a vital platform for the dissemination of high-quality research focused on addressing hazardous materials and their impacts on health and the environment. The journal's commitment to open access facilitates immediate and broad dissemination of research findings, ensuring that essential knowledge reaches a global audience of researchers, professionals, and students eager to advance the field. With its ongoing convergence into 2024, the Journal of Hazardous Materials Letters continues to drive innovation and influence practice in managing hazardous materials for a sustainable future.

JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, published by Taylor & Francis Inc, stands as a key resource in the interdisciplinary field of toxicology and environmental health. Operating under the ISSN 1528-7394 and E-ISSN 1087-2620, this journal maintains a strong presence with a Q2 category ranking in Health, Toxicology and Mutagenesis and a Q3 ranking in Toxicology as of 2023. It aims to disseminate critical findings that address contemporary issues in toxicology and environmental health, emphasizing the implications of environmental agents on human health. The journal offers both subscription and open access options, making cutting-edge research accessible to a diverse readership. With coverage of key topics from 1998 to 2024, it is an essential platform for academics, professionals, and students seeking to stay at the forefront of environmental health sciences.

Environnement Risques & Sante is a prominent journal focused on the intersection of environmental issues, public health, and safety, offering a platform for scholarly discourse on the critical challenges posed by environmental risks to human health. Published by JOHN LIBBEY EUROTEXT LTD, this journal aims to disseminate impactful research that enhances our understanding of toxicology, mutagenesis, and their implications for public health policy and practices. Though it ceased coverage in Scopus in 2021, its historical contributions remain relevant, addressing urgent topics in environmental science and occupational health. Researchers and professionals engaged in these fields will find valuable insights and findings that inform practice and promote sustainable solutions. For interested readers, further exploration of the journal can provide essential knowledge in coping with contemporary environmental health challenges.

Human Gene is an innovative open access journal published by ELSEVIER, dedicated to the ever-evolving field of genetics. Established in 2022, this journal serves as a vital resource for researchers, professionals, and students alike, aiming to facilitate the dissemination of groundbreaking research and advancements in both basic and clinical genetics. With an ISSN of 2773-0441, Human Gene focuses on providing a platform for high-quality studies that investigate genetic mechanisms, their implications in health and disease, and novel therapeutic strategies. The journal currently holds a Q4 ranking in both Genetics and Clinical Genetics categories, reflecting its emerging status within the scientific community, and strives to enhance its impact to better serve an engaged audience. With its base in Amsterdam, Netherlands, Human Gene is committed to making research accessible through its open access model, inviting contributions that advance our understanding of human genetics and foster collaboration across disciplines.

Human Genomics, published by BMC, is a leading open-access journal dedicated to advancing the field of genomics and its applications in health and disease. Since its inception in 2003, the journal has provided a vital platform for researchers to disseminate groundbreaking findings related to genetic research, contributing significantly to areas such as Drug Discovery, Genetics, Molecular Biology, and Molecular Medicine, as reflected in its Q1 and Q2 quartile rankings throughout 2023. With an ISSN of 1473-9542 and an E-ISSN of 1479-7364, Human Genomics not only delivers high-quality, peer-reviewed research but also ensures accessibility to a broader audience, empowering professionals, students, and academics to stay at the forefront of genomic science. Through its rigorous editorial standards and impactful publications, the journal fosters a collaborative environment for innovative research across the globe from its base in the United Kingdom. By promoting open access since its launch, Human Genomics continues to enhance the visibility and impact of genetic studies, making it an essential resource for anyone involved in the rapidly evolving field of human genomics.

MUTATION RESEARCH - FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS is a premier peer-reviewed journal published by Elsevier, dedicated to advancing the understanding of mutagenesis and its broader implications in genetics, health, and molecular biology. With an impressive converged publication history from 1964 to 2024, this journal provides a vital platform for the dissemination of high-quality research findings, contributing significantly to the field's knowledge base. Indexed in Scopus, it holds a Category Quartile ranking of Q3 in Genetics and Q2 in Health, Toxicology, and Mutagenesis, further underscoring its relevance and stature. Access options are available, catering to a diverse audience of researchers, professionals, and students eager to stay informed on the latest developments in mutagenesis research. By bridging experimental studies and theoretical frameworks, the journal plays a crucial role in exploring the fundamental mechanisms underlying genetic mutations and their effects on human health and the environment.

MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, published by Elsevier, is a renowned journal that explores critical advancements in the field of genetic toxicology and environmental mutagenesis. With an ISSN of 1383-5718 and an E-ISSN of 1879-3592, it ranks in Q3 for Genetics and Q2 for Health, Toxicology, and Mutagenesis as of 2023. This journal not only emphasizes the importance of environmental factors in genetic material alterations but also disseminates significant research findings that aid in understanding the implications for public health and safety. Operating from Amsterdam, Netherlands, it serves as a pivotal platform for researchers, professionals, and students, fostering an informed community keen on evolving the parameters of genetic research. Although it currently does not offer open access, the journal's commitment to high-quality peer-reviewed content ensures substantial contributions to the academic literature, enhancing our comprehension of mutagenic processes and their environmental triggers.

CURRENT GENETICS is a prestigious journal published by SPRINGER, dedicated to advancing the field of genetics through the dissemination of high-quality research. With a notable impact factor and ranking in the Q2 category for both Genetics and Medicine (miscellaneous) as of 2023, it firmly establishes itself as a significant resource for the academic community. The journal’s comprehensive scope explores the latest findings in genetic research, along with accompanying interdisciplinary studies, providing a platform for researchers to share innovative ideas and methodologies. ISSN: 0172-8083, E-ISSN: 1432-0983, stands testament to its commitment to scholarly excellence. While Open Access options are not currently available, CURRENT GENETICS remains accessible to a broad audience, promoting a rich exchange of knowledge that supports the vast and evolving discipline of genetics. Since its inception in 1979 and through its converged years till 2024, this journal has played a crucial role in confronting scientific challenges and promoting advancements in genomic medicine and molecular biology. As such, it is an essential read for researchers, professionals, and students keen to remain at the forefront of genetic research.

The International Journal of Toxicology, published by SAGE Publications Inc, serves as a cornerstone of scholarly research in the field of toxicology, with an established history dating back to 1982. This esteemed journal, ISSN 1091-5818 and E-ISSN 1092-874X, functions within the Q3 quartile in Toxicology, ranking 94 out of 133 in the Pharmacology, Toxicology and Pharmaceutics category per Scopus metrics, reflecting its commitment to advancing scientific understanding in this critical area. The journal not only aims to disseminate high-quality research but also encourages open access to vital studies, thus fostering collaboration and innovation among researchers, professionals, and students alike. With a focus on various aspects of toxicology, including but not limited to environmental, clinical, and molecular toxicology, the International Journal of Toxicology is dedicated to bridging gaps in toxicity research and promoting safe practices across numerous disciplines. As it converges towards 2024, the journal continues to play a vital role in shaping the discourse surrounding the implications of exposure to toxic substances in human health and the environment.

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, published by Elsevier, stands as a premier journal in the fields of Genetics and Health, Toxicology and Mutagenesis, boasting a Q1 ranking in both categories for 2023. With an impressive impact factor and rigorous peer-review process, this journal serves as a vital platform for disseminating cutting-edge research and comprehensive reviews regarding the implications of genetic mutations and related health effects. Established in the Netherlands, it has evolved from its inception in the early 1990s to become an essential resource for researchers, professionals, and students alike, facilitating advancements in the understanding of mutation research. Despite not offering an open-access model, the journal ensures a wide reach through institutional subscriptions, emphasizing its commitment to fostering scholarly dialogue and promoting significant findings within the scientific community.